FTY720 suppresses the development of colitis by modulating the trafficking of colitogenic CD4+ T cells in bone marrow.
Author(s) -
Toshimitsu Fujii,
Takanori Kanai∥,
Takuya Tomita,
Yuki Nemoto,
Teruji Totsuka,
Makoto Naganuma,
Masakazu Nagahori,
Mamoru Watanabe
Publication year - 2011
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/17.supplement1.s22
Subject(s) - colitis , bone marrow , medicine , microbiology and biotechnology , cancer research , immunology , chemistry , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom